Immune checkpoint inhibitors-induced large vessel vasculitis: clinical characteristics and management from a European multicentre study.
Cottu A, Delaval L, Forestier A, Tomelleri A, Campochiaro C, Bond M, Dion J, Gury A, Savary X, Dhote R, Betrains A, Bouillet L, Liozon E, Bories E, Petitdemange A, Legendre P, Crichi B, Kerschen P, Carneiro Esteves L, Armengol G, Outh R, Al Tabaa O, Wolff L, Ilzkovitz M, Cherif MY, Laparra A, Dagna L, Bruneval P, Terrier B.
Cottu A, et al. Among authors: al tabaa o.
Rheumatology (Oxford). 2025 Aug 1;64(8):4546-4554. doi: 10.1093/rheumatology/keaf172.
Rheumatology (Oxford). 2025.
PMID: 40139729